Observational Study of ERCP Procedures
This observational study is collecting information about patients who have undergone Endoscopic Retrograde Cholangiopancreatography (ERCP), a procedure used to examine and treat problems in the bile and pancreatic ducts. The study aims to understand factors that might lead to post-ERCP pancreatitis (PEP), a complication. Researchers are looking at data from patients aged 15 and older who had an ERCP at Methodist Dallas Medical Center between January 1, 2000, and December 31, 2025. The main goal is to record details about these procedures over a 25-year period to help improve care and reduce risks.
- Study design
- This is an observational study that plans to include 100 participants. It is collecting data from a registry of patients.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, 'Underwent ERCP,' is measured at 25 years, indicating a long-term data collection period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Endoscopic Retrograde Cholangiopancreatography
At a glance
Conditions
NCT07490132
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Methodist Dallas Medical Center- Clinical Research Institute
Dallas, Texasstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Prashant Kedia, MD · PRINCIPAL_INVESTIGATOR · Methodist Health System
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Underwent ERCP25 years
Patients undergoing ERCPs at Methodist Dallas Medical Center.